The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public alert about a suspected ...

The National Agency for Food and Drug Administration and Control (NAFDAC) has notified Nigerians, including healthcare ...

Roche's strategic acquisition of Poseida Pharmaceuticals positions them as a leader in the allogeneic cell therapy market.

Shares of Halozyme Therapeutics, Inc. HALO were up 5% on Jan. 8 after the company raised its guidance for 2025. The stock gained another 1.8% in after-hours trading. HALO also maintained its full-year ...

The National Agency for Food and Drug Administration and Control, NAFDAC, has alerted Nigerians, including healthcare ...

The National Agency for Food and Drug Administration and Control (NAFDAC) has warned Nigerians to be wary of counterfeit cancer treatment drugs, Phesgo, in circulation.

NAFDAC has warned of a counterfeit Phesgo 600mg/600mg/10ml cancer drug batch, confirming fake labels, tampering, and an invalid batch number.

Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme" or the "Company") today provided a financial update, reiterating full ...

The National Agency for Food and Drug Administration and Control, NAFDAC, has alerted Nigerians, including healthcare providers, about a counterfeit cancer treatment drug, Phesgo 600mg/600mg/10ml ...

The Phesgo 600mg/600mg, labelled with batch number C5290S20, was reported to have been brought in by a patient for administration. The agency disclosed that, at the time of the report the product ...

The National Agency for Food and Drug Administration and Control, NAFDAC has alerted Nigerians, including healthcare ...